Looking into nerve damage in the cornea

Herpes simplex keratitis: A brief clinical overview

The aim of our minireview is to provide a brief overview of the diagnosis, clinical aspects, treatment options, management, and current literature available regarding herpes simplex keratitis (HSK). This type of corneal viral infection is caused by the herpes simplex virus (HSV), which can affect several tissues, including the cornea. One significant aspect of HSK is its potential to cause recurrent episodes of inflammation and damage to the cornea. After the initial infection, the HSV can establish a latent infection in the trigeminal ganglion, a nerve cluster near the eye. The virus may remain dormant for extended periods. Periodic reactivation of the virus can occur, leading to recurrent episodes of HSK. Factors triggering reactivation include stress, illness, immunosuppression, or trauma. Recurrent episodes can manifest in different clinical patterns, ranging from mild epithelial involvement to more severe stromal or endothelial disease. The severity and frequency of recurrences vary among individuals. Severe cases of HSK, especially those involving the stroma and leading to scarring, can result in vision impairment or even blindness in extreme cases. The cornea's clarity is crucial for good vision, and scarring can compromise this, potentially leading to visual impairment. The management of HSK involves not only treating acute episodes but also implementing long-term strategies to prevent recurrences and attempt repairs of corneal nerve endings via neurotization. Antiviral medications, such as oral Acyclovir or topical Ganciclovir, may be prescribed for prophylaxis. The immune response to the virus can contribute to corneal damage. Inflammation, caused by the body's attempt to control the infection, may inadvertently harm the corneal tissues. Clinicians should be informed about triggers and advised on measures to minimize the risk of reactivation. In summary, the recurrent nature of HSK underscores the importance of both acute and long-term management strategies to preserve corneal health and maintain optimal visual function.

Black carbon induces complement activation via NLRP3 inflammasome in human corneal epithelial cells

PURPOSE

To investigate the effect of black carbon (BC) particles on complement activation in human corneal epithelial cells (HCECs), and determine whether this effect can be attenuated by inhibiting the NLPR3 inflammasome pathway.

MATERIALS AND METHODS

HCECs were treated with fresh BC (FBC) or ozone-oxidized BC (OBC) particles at a concentration of 200 μg/ml for 72hours. Complement activation was observed by detecting C5b-9 protein level in cell culture supernatant using ELISA. HCECs were transfected with duplexes of siRNA targeting NLRP3 (NLRP3-siRNA) at 0.1 pmol/µL for 24 hours to inhibit the NLPR3 inflammasome pathway. RT-qPCR was performed to examine the efficacy of NLRP3-siRNA for inhibition; a random siRNA duplex was used for control siRNA.

RESULTS

Both FBC exposure and OBC exposure for 72 hours significantly increased the C5b-9 protein level compared to negative control cells (all P < .05). However, the difference in C5b-9 level after FBC exposure and OBC exposure was not statistically significant (P> .05). NLRP3-siRNA transfection reduced C5b-9 protein levels in FBC treated and OBC treated HCECs compared to control (lowered by 27% in the FBC treated group and by 23% in the OBC treated group, all P < .05).

CONCLUSIONS

BC particles, including FBC and OBC, triggered complement activation, increasing the protein level of C5b-9 in cultured HCECs. siRNA targeting NLRP3 to inhibit NLRP3 generation reduced C5b-9 protein level in HCECs treated with FBC or OBC particles, indicating that BC induces complement activation potentially through the NLRP3 inflammasome in HCECs.